Schedule 13G ownership disclosure

BioMarin Pharmaceutical Inc

Security class unavailable · CUSIP: 09061G101

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,329,320
Percent of class
9.0900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-019060
Form type
SC 13G/A
Filer
BIOMARIN PHARMACEUTICAL INC
CIK
CIK 1048477
Filed
Feb 12, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub